Mark R. Looney

Mark R. Looney

Auto-generated profile, based on publicly available information

Mark R. Looney

University of California, San Francisco

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
BBBetsy J Barnes
Betsy J Barnes
JAJose M. Adrover
Jose M. Adrover
ABAmelia Baxter-Stoltzfus
Amelia Baxter-Stoltzfus
ABAlain Borczuk
Alain Borczuk
JCJonathan Cools-Lartigue
Jonathan Cools-Lartigue
MEMikala Egeblad
Mikala Egeblad
Coronavirus disease 2019 (COVID-19) is a novel, viral-induced respiratory disease that in ∼10–15% of patients progresses to acute respiratory distress syndrome (ARDS) triggered by a cytokine storm. In this Perspective, autopsy results and literature are presented supporting the hypothesis that a little known yet powerful function of neutrophils—the ability to form neutrophil extracellular traps (NETs)—may contribute to organ damage and mortality in COVID-19. We show lung infiltration of neutrophils in an autopsy specimen from a patient who succumbed to COVID-19. We discuss prior reports linking aberrant NET formation to pulmonary diseases, thrombosis, mucous secretions in the airways, and cytokine production. If our hypothesis is correct, targeting NETs directly and/or indirectly with existing drugs may reduce the clinical severity of COVID-19.

22 March 2017 in Nature
Verified
Journal Article
Open access
PDF file
ELEmma Lefrançais
Emma Lefrançais
GOGuadalupe Ortiz-Muñoz
Guadalupe Ortiz-Muñoz
ACAxelle Caudrillier
Axelle Caudrillier
BMBeñat Mallavia
Beñat Mallavia
FLFengchun Liu
Fengchun Liu
MLMark R. Looney
Mark R. Looney
Direct imaging of the lung microcirculation in mice indicates that it is a major site of mature platelet production from megakaryocytes. Platelets, which are essential for generating clots to stop bleeding, are produced to a large extent in the bone marrow, but indirect evidence points to a pulmonary contribution to their genesis. Emma Lefrançais et al. imaged microcirculation in the lungs of mice and report that the lung serves as a reservoir for haematopoietic progenitors and platelet-releasing megakaryocytes that can be recruited to compensate for bone marrow deficiencies. They estimate that the lung is responsible for around 50% of total platelet production in mice, a finding that positions it as an organ of notable haematopoietic potential. Platelets are critical for haemostasis, thrombosis, and inflammatory responses1,2, but the events that lead to mature platelet production remain incompletely understood3. The bone marrow has been proposed to be a major site of platelet production, although there is indirect evidence that the lungs might also contribute to platelet biogenesis4,5,6,7. Here, by directly imaging the lung microcirculation in mice8, we show that a large number of megakaryocytes circulate through the lungs, where they dynamically release platelets. Megakaryocytes that release platelets in the lungs originate from extrapulmonary sites such as the bone marrow; we observed large megakaryocytes migrating out of the bone marrow space. The contribution of the lungs to platelet biogenesis is substantial, accounting for approximately 50% of total platelet production or 10 million platelets per hour. Furthermore, we identified populations of mature and immature megakaryocytes along with haematopoietic progenitors in the extravascular spaces of the lungs. Under conditions of thrombocytopenia and relative stem cell deficiency in the bone marrow9, these progenitors can migrate out of the lungs, repopulate the bone marrow, completely reconstitute blood platelet counts, and contribute to multiple haematopoietic lineages. These results identify the lungs as a primary site of terminal platelet production and an organ with considerable haematopoietic potential.

2 July 2012 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
ACAxelle Caudrillier
Axelle Caudrillier
KKKai Kessenbrock
Kai Kessenbrock
BGBrian M. Gilliss
Brian M. Gilliss
JNJohn X. Nguyen
John X. Nguyen
MMMarisa B. Marques
Marisa B. Marques
MLMark R. Looney
Mark R. Looney
There is emerging evidence that platelets are major contributors to inflammatory processes through intimate associations with innate immune cells. Here, we report that activated platelets induce the formation of neutrophil extracellular traps (NETs) in transfusion-related acute lung injury (TRALI), which is the leading cause of death after transfusion therapy. NETs are composed of decondensed chromatin decorated with granular proteins that function to trap extracellular pathogens; their formation requires the activation of neutrophils and release of their DNA in a process that may or may not result in neutrophil death. In a mouse model of TRALI that is neutrophil and platelet dependent, NETs appeared in the lung microvasculature and NET components increased in the plasma. We detected NETs in the lungs and plasma of human TRALI and in the plasma of patients with acute lung injury. In the experimental TRALI model, targeting platelet activation with either aspirin or a glycoprotein IIb/IIIa inhibitor decreased NET formation and lung injury. We then directly targeted NET components with a histone blocking antibody and DNase1, both of which protected mice from TRALI. These data suggest that NETs contribute to lung endothelial injury and that targeting NET formation may be a promising new direction for the treatment of acute lung injury.

8 February 2018 in JCI Insight
Verified
Journal Article
Open access
PDF file
ELEmma Lefrançais
Emma Lefrançais
BMBeñat Mallavia
Beñat Mallavia
HZHanjing Zhuo
Hanjing Zhuo
CCCarolyn S. Calfee
Carolyn S. Calfee
MLMark R. Looney
Mark R. Looney
Neutrophils dominate the early immune response in pathogen-induced acute lung injury, but efforts to harness their responses have not led to therapeutic advancements. Neutrophil extracellular traps (NETs) have been proposed as an innate defense mechanism responsible for pathogen clearance, but there are concerns that NETs may induce collateral damage to host tissues. Here, we detected NETs in abundance in mouse models of severe bacterial pneumonia/acute lung injury and in human subjects with acute respiratory distress syndrome (ARDS) from pneumonia or sepsis. Decreasing NETs reduced lung injury and improved survival after DNase I treatment or with partial protein arginine deiminase 4 deficiency ( PAD4 +/– ). Complete PAD4 deficiency ( PAD4 –/– ) reduced NETs and lung injury but was counterbalanced by increased bacterial load and inflammation. Importantly, we discovered that the lipoxin pathway could be a potent modulator of NET formation, and that mice deficient in the lipoxin receptor ( Fpr2 –/– ) produced excess NETs leading to increased lung injury and mortality. Lastly, we observed in humans that increased plasma NETs were associated with ARDS severity and mortality, and lower plasma DNase I levels were associated with the development of sepsis-induced ARDS. We conclude that a critical balance of NETs is necessary to prevent lung injury and to maintain microbial control, which has important therapeutic implications.

1 February 2022 in American Journal of Respiratory Cell and Molecular Biology
Verified
Journal Article
Open access
HKHrishikesh S. Kulkarni
Hrishikesh S. Kulkarni
JLJanet S. Lee
Janet S. Lee
JBJulie A. Bastarache
Julie A. Bastarache
WKWolfgang Kuebler
Wolfgang Kuebler
GDGregory P. Downey
Gregory P. Downey
GMGutavo Matute-Bello
Gutavo Matute-Bello
Advancements in methods, technology, and our understanding of the pathobiology of lung injury have created the need to update the definition of experimental acute lung injury (ALI). We queried 50 participants with expertise in ALI and acute respiratory distress syndrome using a Delphi method composed of a series of electronic surveys and a virtual workshop. We propose that ALI presents as a “multidimensional entity” characterized by four “domains” that reflect the key pathophysiologic features and underlying biology of human acute respiratory distress syndrome. These domains are 1) histological evidence of tissue injury, 2) alteration of the alveolar–capillary barrier, 3) presence of an inflammatory response, and 4) physiologic dysfunction. For each domain, we present “relevant measurements,” defined as those proposed by at least 30% of respondents. We propose that experimental ALI encompasses a continuum of models ranging from those focusing on gaining specific mechanistic insights to those primarily concerned with preclinical testing of novel therapeutics or interventions. We suggest that mechanistic studies may justifiably focus on a single domain of lung injury, but models must document alterations of at least three of the four domains to qualify as “experimental ALI.” Finally, we propose that a time criterion defining “acute” in ALI remains relevant, but the actual time may vary based on the specific model and the aspect of injury being modeled. The continuum concept of ALI increases the flexibility and applicability of the definition to multiple models while increasing the likelihood of translating preclinical findings to critically ill patients.

1 June 2006 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MLMark R. Looney
Mark R. Looney
Xiao SuXiao Su
Xiao Su
JZJessica A. Van Ziffle
Jessica A. Van Ziffle
CLClifford A. Lowell
Clifford A. Lowell
MMMichael A. Matthay
Michael A. Matthay
Transfusion-related acute lung injury (TRALI) is the most common cause of transfusion-related mortality. To explore the pathogenesis of TRALI, we developed an in vivo mouse model based on the passive transfusion of an MHC class I (MHC I) mAb (H2Kd) to mice with the cognate antigen. Transfusion of the MHC I mAb to BALB/c mice produced acute lung injury with increased excess lung water, increased lung vascular and lung epithelial permeability to protein, and decreased alveolar fluid clearance. There was 50% mortality at a 2-hour time point after Ab administration. Pulmonary histology and immunohistochemistry revealed prominent neutrophil sequestration in the lung microvasculature that occurred concomitantly with acute peripheral blood neutropenia, all within 2 hours of administration of the mAb. Depletion of neutrophils by injection of anti-granulocyte mAb Gr-1 protected mice from lung injury following MHC I mAb challenge. FcRγ–/– mice were resistant to MHC I mAb–induced lung injury, while adoptive transfer of wild-type neutrophils into the FcRγ–/– animals restored lung injury following MHC I mAb challenge. In conclusion, in a clinically relevant in vivo mouse model of TRALI using an MHC I mAb, the mechanism of lung injury was dependent on neutrophils and their Fcγ receptors.